| # | Drug | Count |
|---|---|---|
| 0 | VALPROATE SODIUM | 8 |
| 1 | FUROSEMIDE | 7 |
| 2 | LEVETIRACETAM | 7 |
| 3 | LEVETIRACETAM IN SODIUM CHLORIDE | 6 |
| 4 | LEVETIRACETAM INJECTION | 6 |
| 5 | LEVETIRACETAM ORAL | 6 |
| 6 | SPIRONOLACTONE | 6 |
| 7 | BRIVARACETAM | 5 |
| 8 | LAMOTIRIGINE | 5 |
| 9 | LAMOTRIGINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VELMANASE ALFA-TYCV | 1 | 0.0179 |
| 1 | SECNIDAZOLE | 1 | 0.0035 |
| 2 | BRIVARACETAM | 5 | 0.0005 |
| 3 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 4 | ETHOSUXIMIDE | 1 | 0.0004 |
| 5 | LAMIVUDINE AND ZIDOVUDINE | 3 | 0.0004 |
| 6 | VALPROATE SODIUM | 8 | 0.0004 |
| 7 | BUROSUMAB | 2 | 0.0003 |
| 8 | ASFOTASE ALFA | 3 | 0.0003 |
| 9 | LEVOCARNITINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 1 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 2 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |